Takashi Tahata

Affiliations

Chugai Pharmaceutical Co., Ltd., 2-1-1, Nihonbashi-Muromachi, Chuo-ku, Tokyo 103-8324, Japan.

Publications (1)

First-line onartuzumab plus erlotinib treatment for patients with MET-positive and EGFR mutation-positive non-small-cell lung cancer.

Cancer treatment and research communications

Avec: Kazuma Kishi , Hiroshi Sakai , Takashi Seto , Toshiyuki Kozuki , Makoto Nishio , Fumio Imamura , Hiroshi Nokihara , Miyako Satouchi , Shintaro Nakagawa , Kazuhiko Nakagawa

Réseau de co-auteurs

Kazuma Kishi 1 collaboration

Hiroshi Sakai 1 collaboration

Takashi Seto 1 collaboration

Toshiyuki Kozuki 1 collaboration

Makoto Nishio 1 collaboration

Fumio Imamura 1 collaboration

Hiroshi Nokihara 1 collaboration

Miyako Satouchi 1 collaboration

Shintaro Nakagawa 1 collaboration

Kazuhiko Nakagawa 1 collaboration